Oxford Business Group and Abu Dhabi Health Services Company team up for Covid-19 Response Report 

United Arab Emirates Abu Dhabi: A new Covid-19 Response Report (CRR), produced by Oxford Business Group (OBG) in partnership with Abu Dhabi Health Services Company (SEHA), shines a spotlight on the advanced medical and digital ecosystems that are paving the way for the emirate to become a global hub for health tourism and life sciences.

The report provides an in-depth analysis of Abu Dhabi’s evolving health sector, and the role in paving the way for economic recovery from the pandemic-related downturn, in an easy-to-navigate and accessible format that includes key data and infographics. 

It charts the emirate’s effective and innovative health care response to the pandemic, which included a swift scaling up in testing capacity and the introduction of the locally developed Al Hosn track and trace application.

The CRR also examines the UAE’s world-leading Covid-19 vaccination rollout, which has enabled the country to move forward with its broader recovery plans and reopen key sectors of the economy. 

The vaccine clinical trials were undertaken in Abu Dhabi during the pandemic and future opportunities for the emirate to become a key link in the global medical R&D industry are another focus. In this section, the report highlights the joint-venture between the local company G42 Healthcare and Sinopharm to produce Covid-19 vaccines in Abu Dhabi, paving the way for the emirate to carve a niche as an industry hub.

The CRR also considers the positive post-pandemic growth prospects for digital health care solutions in Abu Dhabi, such as telemedicine and online health solutions, which are already benefiting from increased uptake on the back of the emirate’s digital transformation. 

In addition, it explores SEHA’s wide-ranging contribution to Abu Dhabi’s health service provision before and throughout the pandemic, which includes working with other stakeholders to scale up mass testing and treatment capacity, providing public health messages and developing educational and training programmes. 

The report also includes an in-depth interview with Tarek Fathey, SEHA’s Group CEO, in which he shares his thoughts on several topical issues, including the emirate’s growing reputation as an international medical destination for specialist care.

“The launch of Sheikh Shakhbout Medical City Abu Dhabi in November 2019 cemented the emirate’s role as a key player in the medical tourism market, allowing people in the region and beyond to access the same calibre of care, expertise and talent they would expect in other established markets,” he said. “Moreover, this has helped us attract some of the best talent from around the world to work in our medical facilities.”

Jana Treeck, OBG’s Managing Director for the Middle East, said that sustained investment in improving health care systems and medical infrastructure meant Abu Dhabi was able to respond quickly and effectively to the pandemic. 

“The UAE and Abu Dhabi had developed a modern and effective public health system before the arrival of Covid-19, which included the rapid adoption of digital solutions and new technologies in health care,” Treeck said. “With digital transformation accelerating further as a result of the pandemic, we expect to see opportunities emerging in Abu Dhabi’s health care sector for providers to develop new services that will enhance outcomes and meet rising demand from both local and international patients.”

The CRR on Abu Dhabi’s health care sector forms part of a series of tailored reports which OBG is currently producing with its partners, alongside other highly relevant, go-to research tools, including a range of country-specific Growth and Recovery Outlook articles and interviews. 

About Oxford Business Group:

Oxford Business Group (OBG) is a global research and advisory company with a presence in over 30 countries, spanning Africa, the Middle East, Asia and the Americas. It is recognised internationally as a distinctive and respected provider of on-the-ground intelligence on world’s fastest-growing markets, termed The Yellow Slice, in reference to OBG’s corporate colour. 

Through its range of products – Economic News and Views; OBG CEO Surveys; OBG Events and Conferences; Global Platform, which hosts exclusive video interviews; and The Report publications – as well as its Advisory division, OBG offers comprehensive and accurate analysis of macroeconomic and sector-level developments for sound investment opportunities and business decisions. 

OBG provides business intelligence to its subscribers through multiple platforms, including its direct 6 million verified subscribers, Dow Jones Factiva subscribers, the Bloomberg Professional Services subscribers, Refinitiv’s (previously Thomson Reuters) Eikon subscribers and more.

About SEHA:

The Abu Dhabi Health Services Company PJSC–SEHA – is an independent, public joint stock company created to develop the curative activities of the public healthcare system in Abu Dhabi. The company owns and operates all the public hospitals and clinics of the Emirate of Abu Dhabi. 

SEHA is part of ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy.

SEHA is committed to continuous improvement of customer care to recognized international standards and providing the community with world-class healthcare. SEHA operates 13 hospitals with 3,385 beds, 70 ambulatory care, family care and urgent care centers and 2 blood banks. Its facilities accommodate 117,162 inpatients annually and conduct 43,262 surgeries, as well as treating more than five million outpatients. SEHA is one of the largest integrated healthcare providers in the Middle East with more than 18,000 doctors, nurses, ancillary care, and administrative personnel.